Google
Trusted Resources: News & Events
Latest announcements and gatherings
MARAC Advisory Statement: COVID-19 Update
August 26, 2021 — The Sickle Cell Disease Association of America Medical and Research Advisory Committee reminds the sickle cell community that the COVID-19 pandemic is not over and that news is moving quickly in many areas.
MARAC recommendations are making a minor shift to emphasize a more individualized approach:
- Continue to recommend vaccination against COVID. For booster dose of vaccine, currently SCD is not eligible but expect changes in CDC guidance.
- Continue to recommend general precautions: wearing masks, keeping physical distancing, good ventilation, and washing hands. These are public health measures.
- Recommend neutralizing monoclonal antibodies (mAb) – (Regeneron) as early treatment for mild symptomatic COVID in individuals with SCD [<10d after the test, age 12y+, wt 88 lb+ (40kg+), not hospitalized, not newly on oxygen]. Encourage getting tested if you have COVID symptoms. Possible prophylactic treatment with Regeneron antibodies if exposed to COVID.
- No general recommendation for all individuals with SCD to stay home nor all to return to in-person activities. Help patients and families make individualized assessments of risk and trade-offs of returning to work or school in-person. Factors to consider were listed in MARAC July 2020 “checklist for return to school” (plus vaccination status): the community’s rates of COVID and variants, vaccination status, family socioeconomic situation, ventilation and other protective measures in the building, mental health needs, educational needs.
Read the full statement for more information on the above.
+myBinderRelated Content
-
State Of The CONSORTIUM – Sickle Cell Community ConsortiumJoin the Sickle Cell Community Consortiu...
-
Q&A With Regina Hartfield, New CEO of the SCDAARegina Hartfield is set to become the pr...
-
Conditions screened by stateWhile all states require newborn screeni...
-
Sickle Cell Information CenterThis site is a collaboration between mem...
-
Sickle Cell Disease Patients Community of TanzaniaThe main objective Sickle Cell Disease P...
-
Supporters of Families With Sickle Cell DiseaseSupporters of Families with Sickle Cell ...
-
Gene Therapy: What You Need to Know (Warrior FAQs)Two gene therapies were recently approve...
To improve your experience on this site, we use cookies. This includes cookies essential for the basic functioning of our website, cookies for analytics purposes, and cookies enabling us to personalize site content. By clicking on 'Accept' or any content on this site, you agree that cookies can be placed. You may adjust your browser's cookie settings to suit your preferences. More Information
The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.
Powered by
Support for this site is provided by
This platform is made possible through a partnership with the Sickle Cell Disease Association of America, Inc. (SCDAA) and its member organizations. SCDAA's mission is to advocate for people affected by sickle cell conditions and empower community-based organizations to maximize quality of life and raise public consciousness while advancing the search for a universal cure.